96 related articles for article (PubMed ID: 2433377)
1. [Diluted albumin-dextran 40 combination in treating arteriopathy of the lower extremities by normovolemic hemodilution. The rheological effects].
Stoltz JF; Chevraud C; Voisin P; Burdin D; Streiff F; Laxenaire MC
J Mal Vasc; 1986; 11(4):344-50. PubMed ID: 2433377
[TBL] [Abstract][Full Text] [Related]
2. [Intentional normovolemic hemodilution in the medical treatment of lower limb arteritis].
Chevreaud C; Thouvenot P; Burdin D; Laxenaire MC; Fiévé G
Ann Fr Anesth Reanim; 1986; 5(3):223-8. PubMed ID: 3777544
[TBL] [Abstract][Full Text] [Related]
3. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
4. [Rheologic effects of normovolemic hemodilution].
Kuznetsov NA; Aleksandrova NP; Bogdanov AE; Rogulenko RV
Anesteziol Reanimatol; 1990; (2):18-22. PubMed ID: 1698041
[TBL] [Abstract][Full Text] [Related]
5. Organ blood supply and tissue oxygenation after limited normovolemic hemodilution with 3% versus 6% Dextran-60.
Brückner UB; Kefalianakis F; Krieter H; Messmer K
Infusionsther Transfusionsmed; 1993 Aug; 20(4):130-9. PubMed ID: 7691288
[TBL] [Abstract][Full Text] [Related]
6. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
7. [Can normovolemic hemodilution really modify blood flow in the limbs?].
Guerrini M; Pieragalli D; Acciavatti A; Cappelli R; Pecchi S; Forconi S; Di Perri T
Ric Clin Lab; 1983; 13 Suppl 3():439-44. PubMed ID: 6673027
[TBL] [Abstract][Full Text] [Related]
8. [In vivo effects of plasma substitutes on the rheologic properties of blood].
Donner M; De Wachter P; Cauchois G; Gentils M; Kurtz M; Laxenaire MC; Stoltz JF
J Mal Vasc; 1993; 18(2):126-33. PubMed ID: 7688783
[TBL] [Abstract][Full Text] [Related]
9. [In vitro modification of plasma viscosity and erythrocyte aggregation by four plasma substitutes].
Brehme S; Keysser G; Turowski A; Schmidt HH; Lerche D
Z Gesamte Inn Med; 1993 Dec; 48(12):605-8. PubMed ID: 7511855
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of isovolemic hemodilution with 3% albumin, dextran-40, and prophylactic enoxaparin (LMWH) on thrombus formation at venous microanastomosis in rats.
Farina JA; Piccinato CE; Campos AD; Rossi MA
Microsurgery; 2006; 26(6):456-64. PubMed ID: 16924631
[TBL] [Abstract][Full Text] [Related]
11. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution].
Hensel M; Wrobel R; Volk T; Pahlig H; Kox WJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):481-7. PubMed ID: 9019177
[TBL] [Abstract][Full Text] [Related]
12. [Hemorheologic changes in preoperative hemodilution during total hip replacement. Randomized study comparing hydroxyethyl starch 200,000/0.62 (HES) and a dextran 60,000].
Lartigue B; Barre J; Nguyen P; Potron G
J Mal Vasc; 1994; 19(1):27-31. PubMed ID: 7517991
[TBL] [Abstract][Full Text] [Related]
13. [Volume substitution in acute normovolemic hemodilution. 5% human albumin vs. 6% hydroxyethyl starch].
von Bormann B; Sticher J; Ratthey K; Idelberger R; Hempelmann G
Infusionstherapie; 1990 Jun; 17(3):142-6. PubMed ID: 1697284
[TBL] [Abstract][Full Text] [Related]
14. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
15. [Intentional normovolemic hemodilution (preliminary results)].
Basile M; Celi S; Micali C; Mandolfino T; Natale S
Chir Ital; 1984 Feb; 36(1):17-25. PubMed ID: 6084565
[TBL] [Abstract][Full Text] [Related]
16. Normovolemic hemodilution in peripheral arterial disease.
Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
[TBL] [Abstract][Full Text] [Related]
18. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
19. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
20. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
Brehme S; Keysser G; Turowski A; Schmidt HH
Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
